Trends in the Global Organoid Technology and Industry: From Organogenesis in a Dish to the Commercialization of Organoids

The document discusses the progress in organoid technology, which creates simplified, miniaturized versions of organs for research. Organoids have been used to model diseases, develop drugs, and study organ development, and have been generated from various tissues, including liver, kidney, heart, and skin. Notably, hair-bearing human skin organoids have been created from pluripotent stem cells. Organoids have been used to study infectious diseases like COVID-19 and Zika virus, in cancer research to test drug responses, and to correct genetic diseases like cystic fibrosis and muscular dystrophy in patient-derived cells. The document also explores the commercialization of organoids and their potential in personalized medicine.